CRP and cancer: Although large datasets focused specifically on ICI-associated thrombosis are still evolving, AI models can integrate multi-modal data—including clinical variables, existing biomarkers (such as D-dimer and C-reactive protein), genomic data, imaging features, and ICI response indicators—from broader cancer and thrombosis datasets [121].